The Oncosearch | Oncotarget

Multiclonality of ER expression in DCIS – Implications for clinical practice and future research Editorial

Mangesh A. Thorat

Published Jun 1, 2023 · Vol. 14, No. 1 · pp. 719-720

Keywords: ductal carcinoma in situ (DCIS), invasive breast cancer, ER, recurrence, clonality

Association of mutation and expression of the brother of the regulator of imprinted sites (BORIS) gene with breast cancer progression Research Paper

Mohammad Salman Akhtar, Naseem Akhter, Arshi Talat, Raed A. Alharbi, Abdulmajeed A.A. Sindi, Faisal Klufah, Hanan E. Alyahyawi, Abdulmohsen Alruwetei, Abrar Ahmad, Mazin A. Zamzami, SVS Deo, Syed Akhtar Husain, Osama A. Badi, Mohammad Jahir Khan

Published May 16, 2023 · Vol. 14, No. 1 · pp. 528-541

Keywords: BORIS, breast cancer, mutation, transcription factor, PCR-SSCP

Are cis-spliced fusion proteins pathological in more aggressive luminal breast cancer? Editorial

Chia-Chia Liu, Xiao-Song Wang

Published May 12, 2023 · Vol. 14, No. 1 · pp. 595-596

Keywords: luminal B breast cancer, RAD51AP1-DYRK4, MEK inhibitor, chimerical transcript

Systemic treatment for brain metastasis in HER2- positive advanced breast cancer: what have we learned so far? Editorial

Marta Vaz Batista, José Perez-Gracia, Inês Eiriz, Maria Gion, Antonio Llombart, Sofia Braga, Javier Cortés

Published May 12, 2023 · Vol. 14, No. 1 · pp. 701-702

Keywords: brain metastasis, HER2+ breast cancer

G-protein-coupled receptor 141 mediates breast cancer proliferation and metastasis by regulating oncogenic mediators and the p-mTOR/p53 axis Research Paper

Monalisa Parija, Amit K. Adhya, Sandip K. Mishra

Published May 11, 2023 · Vol. 14, No. 1 · pp. 466-480

Keywords: G-protein-coupled receptor 141, cell migration, metastasis, p-mTOR, p53

Correction: Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer Correction

Astrid Escudero-Esparza, Michael Bartoschek, Chrysostomi Gialeli, Marcin Okroj, Sioned Owen, Karin Jirström, Akira Orimo, Wen G. Jiang, Kristian Pietras, Anna M. Blom

Published May 4, 2023 · Vol. 14, No. 1 · pp. 481-482

ERβ as a mediator of estrogen signaling in inflammatory breast cancer Editorial

Harika Nagandla, Christoforos Thomas

Published May 2, 2023 · Vol. 14, No. 1 · pp. 576-578

Keywords: inflammatory breast cancer, IBC, ERβ, metastasis, actin based cell migration

Differential silencing of STAT3 isoforms leads to changes in STAT3 activation Research Paper

Inbal Shamir, Ilan Tsarfaty, Gidi Paret, Yael Nevo-Caspi

Published Apr 17, 2023 · Vol. 14, No. 1 · pp. 366-376

Keywords: STAT3, STAT3 isoforms, breast cancer, cancer diagnosis, cancer therapy

Tumor necroptosis promotes metastasis through modulating the interplay between tumor and host immunity Editorial

Zhaoshan Liu, Swati Choksi, Zheng-Gang Liu

Published Apr 4, 2023 · Vol. 14, No. 1 · pp. 295-296

Keywords: necroptosis, breast cancer, metastasis, E-cadherin, immunity

Crossroads: the role of biomarkers in the management of lumps in the breast Research Perspective

Georg F. Weber

Published Apr 1, 2023 · Vol. 14, No. 1 · pp. 358-362

Keywords: breast cancer premalignant lesion, biomarker, biopsy, mammography

EGFR endocytosis: more than meets the eye Editorial Perspective

Aysegul Sapmaz, Ayse Elif Erson-Bensan

Published Mar 31, 2023 · Vol. 14, No. 1 · pp. 297-301

Keywords: EGFR, SNX3, USP32, endocytosis

Crosstalk between triple negative breast cancer and microenvironment Review

Karly Smrekar, Artem Belyakov, Kideok Jin

Published Mar 25, 2023 · Vol. 14, No. 1 · pp. 284-293

Keywords: triple negative breast cancer, tumor microenvironment, current therapy

Polyisoprenylated cysteinyl amide inhibitors deplete singly polyisoprenylated monomeric G-proteins in lung and breast cancer cell lines Research Paper

Nada Tawfeeq, Jassy Mary S. Lazarte, Yonghao Jin, Matthew D. Gregory, Nazarius S. Lamango

Published Mar 15, 2023 · Vol. 14, No. 1 · pp. 243-257

Keywords: PCAIs, G-proteins, KRAS, RHOA, RAC1

Genetic modifiers of p53: opportunities for breast cancer therapies Editorial Perspective

Prabin Dhangada Majhi, Aman Sharma, D. Joseph Jerry

Published Mar 11, 2023 · Vol. 14, No. 1 · pp. 236-241

Keywords: p53, Li-Fraumeni syndrome, genetic modifiers, breast cancer, DNA repair

Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (MTAP) loss Research Paper

Maroun Bou Zerdan, Prashanth Ashok Kumar, Elio Haroun, Nimisha Srivastava, Jeffrey Ross, Abirami Sivapiragasam

Published Feb 25, 2023 · Vol. 14, No. 1 · pp. 178-187

Keywords: breast cancer, metastatic, MTAP loss

The nuclear envelope and metastasis Editorial

Emily Hansen, James M. Holaska

Published Feb 17, 2023 · Vol. 14, No. 1 · pp. 317-320

Keywords: emerin, metastasis, mechanotransduction, breast cancer, nucleoskeleton

What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP’s prognostic ability in different cancer types Review

Christian Mark Farag, Ryan Antar, Sinan Akosman, Matthew Ng, Michael J. Whalen

Published Feb 15, 2023 · Vol. 14, No. 1 · pp. 153-172

Keywords: HALP score, biomarker, prognosis, cancer, survival

The “extreme phenotype approach” applied to male breast cancer allows the identification of rare variants of ATR as potential breast cancer susceptibility alleles Research Paper

Martin Chevarin, Diana Alcantara, Juliette Albuisson, Marie-Agnès Collonge-Rame, Céline Populaire, Zohair Selmani, Amandine Baurand, Caroline Sawka, Geoffrey Bertolone, Patrick Callier, Yannis Duffourd, Philippe Jonveaux, Yves-Jean Bignon, Isabelle Coupier, François Cornelis, Christophe Cordier, Monique Mozelle-Nivoix, Jean-Baptiste Rivière, Paul Kuentz, Christel Thauvin, Romain Boidot, François Ghiringhelli, Marc O'Driscoll, Laurence Faivre, Sophie Nambot

Published Feb 1, 2023 · Vol. 14, No. 1 · pp. 111-125

Keywords: male breast cancer, genetic predisposition to cancer, exome sequencing, ATR, extreme phenotype

Correction: Synergistic antitumor activity by combining trastuzumab with retinoic acid in HER2 positive human breast cancer cells Correction

Fiorella Vanderhoeven, Analía Lourdes Redondo, Ana Laura Martinez, Laura María Vargas-Roig, Angel Matias Sanchez, Marina Inés Flamini

Published Jan 14, 2023 · Vol. 14, No. 1 · pp. 53-53

Candidate drugs associated with sensitivity of cancer cell lines with DLST amplification or high mRNA levels Research Paper

Christina Kuhn, Myriam Boeschen, Manuel Philip, Torsten Schöneberg, Doreen Thor, Susanne Horn

Published Dec 27, 2022 · Vol. 14, No. 1 · pp. 14-20

Keywords: neuroblastoma, drug sensitivity, drug resistance, drug repurposing, DLST

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Multiclonality of ER expression in DCIS – Implications for clinical practice and future research Editorial

Association of mutation and expression of the brother of the regulator of imprinted sites (BORIS) gene with breast cancer progression Research Paper

Are cis-spliced fusion proteins pathological in more aggressive luminal breast cancer? Editorial

Systemic treatment for brain metastasis in HER2- positive advanced breast cancer: what have we learned so far? Editorial

G-protein-coupled receptor 141 mediates breast cancer proliferation and metastasis by regulating oncogenic mediators and the p-mTOR/p53 axis Research Paper

Correction: Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer Correction

ERβ as a mediator of estrogen signaling in inflammatory breast cancer Editorial

Differential silencing of STAT3 isoforms leads to changes in STAT3 activation Research Paper

Tumor necroptosis promotes metastasis through modulating the interplay between tumor and host immunity Editorial

Crossroads: the role of biomarkers in the management of lumps in the breast Research Perspective

EGFR endocytosis: more than meets the eye Editorial Perspective

Crosstalk between triple negative breast cancer and microenvironment Review

Polyisoprenylated cysteinyl amide inhibitors deplete singly polyisoprenylated monomeric G-proteins in lung and breast cancer cell lines Research Paper

Genetic modifiers of p53: opportunities for breast cancer therapies Editorial Perspective

Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (MTAP) loss Research Paper

The nuclear envelope and metastasis Editorial

What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP’s prognostic ability in different cancer types Review

The “extreme phenotype approach” applied to male breast cancer allows the identification of rare variants of ATR as potential breast cancer susceptibility alleles Research Paper

Correction: Synergistic antitumor activity by combining trastuzumab with retinoic acid in HER2 positive human breast cancer cells Correction

Candidate drugs associated with sensitivity of cancer cell lines with DLST amplification or high mRNA levels Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Multiclonality of ER expression in DCIS – Implications for clinical practice and future research Editorial

Association of mutation and expression of the brother of the regulator of imprinted sites (BORIS) gene with breast cancer progression Research Paper

Are cis-spliced fusion proteins pathological in more aggressive luminal breast cancer? Editorial

Systemic treatment for brain metastasis in HER2- positive advanced breast cancer: what have we learned so far? Editorial

G-protein-coupled receptor 141 mediates breast cancer proliferation and metastasis by regulating oncogenic mediators and the p-mTOR/p53 axis Research Paper

Correction: Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer Correction

ERβ as a mediator of estrogen signaling in inflammatory breast cancer Editorial

Differential silencing of STAT3 isoforms leads to changes in STAT3 activation Research Paper

Tumor necroptosis promotes metastasis through modulating the interplay between tumor and host immunity Editorial

Crossroads: the role of biomarkers in the management of lumps in the breast Research Perspective

EGFR endocytosis: more than meets the eye Editorial Perspective

Crosstalk between triple negative breast cancer and microenvironment Review

Polyisoprenylated cysteinyl amide inhibitors deplete singly polyisoprenylated monomeric G-proteins in lung and breast cancer cell lines Research Paper

Genetic modifiers of p53: opportunities for breast cancer therapies Editorial Perspective

Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (MTAP) loss Research Paper

The nuclear envelope and metastasis Editorial

What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP’s prognostic ability in different cancer types Review

The “extreme phenotype approach” applied to male breast cancer allows the identification of rare variants of ATR as potential breast cancer susceptibility alleles Research Paper

Correction: Synergistic antitumor activity by combining trastuzumab with retinoic acid in HER2 positive human breast cancer cells Correction

Candidate drugs associated with sensitivity of cancer cell lines with DLST amplification or high mRNA levels Research Paper